Bragar Eagel & Squire, P.C. is investigating potential claims against Gildan Activewear Inc. on behalf of Gildan stockholders. The investigation concerns whether Gildan violated federal securities laws or engaged in other unlawful business practices. It follows a June 16, 2026 short report by Jehoshaphat Research that alleged Gildan's organic growth has been negative for years and that the company used financial engineering to obscure the decline. On that news, Gildan's stock price fell $11.63 per share, or 18.7%, to close at $50.34 per share. The law firm encourages investors who suffered losses to contact partners Brandon Walker or Melissa Fortunato.
Gildan Activewear Inc.Short report alleges financial engineering and negative organic growth, causing 18.7% stock drop.